| |
|
Terry McGuire is a Co-Founder and General Partner of Polaris Venture Partners based in the Boston office. Terry focuses on life sciences investments.
Prior to starting Polaris, Terry spent seven years at Burr, Egan, Deleage & Co. investing in early stage medical and information technology companies. Terry began his career in venture capital at Golder, Thoma and Cressey in Chicago.
Terry has co-founded three companies: Inspire Pharmaceuticals, AIR (Advanced Inhalation Research, Inc.), and MicroCHIPS.
Terry represents Polaris on the boards of directors of Acceleron Pharma, Adimab, Arsenal Medical, Inc., Cerulean Pharma Inc., Ironwood Pharmaceuticals, Life Line Screening, MicroCHIPS, Inc., Pulmatrix Inc., and Trevena Inc. He has also served on the boards of Akamai, Aspect Medical Systems, Cubist Pharmaceuticals, deCODE Genetics (DCGN), GlycoFi, Transform Pharmaceuticals, and Remon Medical Technologies.
Terry serves on the boards of the Thayer School of Engineering, Dartmouth College (Chair); The National Venture Capital Association (Chair); MIT’s The David H. Koch Institute for Integrative Cancer Research, and The Arthur Rock Center for Entrepreneurship at HBS.
MBA from Harvard Business School. MS in engineering from The Thayer School at Dartmouth College. BS in physics and economics from Hobart College.
Terry is a recipient of the Albert Einstein Award for Outstanding Achievement in the Life Sciences, awarded by Forbes/Gottlieb Medical Technology Investor, Harvard MIT Biomedical Engineering Center, the New Jerusalem Foundation, the Jerusalem Development Authority, and Rodman and Renshaw.
|
